Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Not stated	2025-12-08		NCT06782971

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Australian National University	7
Cancer Institute NSW	1
Clinical Hub for Interventional Research (CHOIR)	4
The University of New South Wales	23

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Canberra Health Services	Canberra	Australia	3
Prince of Wales Hospital	Sydney	Australia	12
Royal North Shore Hospital	Sydney	Australia	14
Westmead Hospital	Westmead	Australia	128